Study design and rationale of the TXL-CAP trial: a randomized, double-blind, placebo-controlled, multicenter clinical trial assessing the effect of Tongxinluo capsules on the stability of coronary atherosclerotic plaques.

Recent clinical trials have demonstrated a protective effect in using traditional Chinese medicine Tongxinluo (TXL) capsule to treat atherosclerosis. However, clinical evidence of the effects of TXL treatment on coronary plaque vulnerability is unavailable. In response, we developed this study to in...

Full description

Bibliographic Details

Published in:	Journal of Geriatric Cardiology Vol. 22; no. 7; pp. 615 - 625
Main Authors:	NI, Mei, TI, Yun, QI, Yan, ZHANG, Meng, Duan, Dayue Darrel, YAO, Chen, JIA, Zhen-Hua, ZHANG, Yun, BU, Pei-Li
Format:	protocol tables/charts Journal Article
Published:	Journal of Geriatric Cardiology Jul2025
Online Access:	View this record in EBSCOhost